THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)
KW
KRISTINA WEGER
Registered · LDAActive
Background
Career
CG
WASHINGTON, DC · current
The past 12 months
Clients
1
past 12 months
Filings
1
past 12 months
Agencies contacted
Centers For Medicare and Medicaid Services (CMS)Executive Office of the President (EOP)HOUSE OF REPRESENTATIVESHealth & Human Services, Dept of (HHS)Labor, Dept of (DOL)SENATE
Specific issues
H.R. 3838/S2296 Pharmacy issues related to the National Defense Authorization Act, FY2026 HR. 6400 / S. 4106 - Rx Access, Choice, Cost Equity, and Supply Stability (Rx ACCESS) Act
Issues related to competition in the health care marketplace.
Issues related to prior authorization; ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model
Issues relating to implementation of the No Surprises Act
S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S.526, Pharmacy Benefit Manager Transparency Act; P.L. 119-75 Consolidated Appropriations Act, 2026 (H.R.7148) Issues related to the specialty drug market. H.R. 5582/S. 2355, Patients Deserve Price Tags Act
Clients
Sources
This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗
Recent filings1
lda.gov →